Numerous patients with metabolic syndrome exhibit elevated inflammatory marker concentrations, including C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6). This evidence concerns the gene CRP and metabolic syndrome.